Filana Therapeutics

Filana Therapeutics

FLNA· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -16.1% in FY2025

Richard J. Barry is the CEO of Filana Therapeutics and was paid $1.5M in FY2025 (Dec), down 91%.

Pay$100 in the stock at the end of FY22 → $7
CEO pay is from each Filana Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Richard J. BarryFY2025
  2. 2Eric J. SchoenFY2025
  3. 3R. Christopher CookFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Filana Therapeutics paid its 3 named executives $3.2M in total in FY2025 (Dec). CEO Richard J. Barry was paid $1.5M of that.

Name
Richard J. BarryPresident and Chief Executive Officer
Eric J. SchoenChief Financial Officer
R. Christopher CookChief Operating and Legal Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers19

See all

The FY2025 (Dec) proxy of Filana Therapeutics names 19 peer companies for pay. Among Filana Therapeutics and these peers, CEO pay was 10th highest of 11 and total shareholder return was 9th highest of 11.

10th highest of 11in Filana Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$1.4M$30.6M

9th highest of 11in Filana Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

-$67$244

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Claude Nicaise, M.D.Chair · 2 yr on the boardIndependentNominating and Governance—Paid as an executive
  • Pierre GravierDirector · 2 yr on the boardIndependent—Paid as an executive
  • Robert Anderson, Jr.Director · 2 yr on the boardIndependentNominating and Governance—Paid as an executive
  • Dawn Carter BirDirector · 0 yr on the boardIndependent—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

  1. Pay
    Filana Therapeutics CEO pay fell 91% to $1.5M. The stock fell 16% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Filana Therapeutics CFO pay fell 78% to $830.0K. The stock fell 16% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Filana Therapeutics Chief Operating and Legal Officer pay fell 75% to $819.0K. The stock fell 16% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Filana Therapeutics Chief Operating and Legal Officer pay rose 160% to $3.3M. The stock fell 90% in FY2024 (Dec).
    DEF 14A
  5. Board
    Dawn Carter Bir joined the board of Filana Therapeutics. Dawn Carter Bir now sits on 3 public boards.
    3
  6. Pay
    Filana Therapeutics CEO pay rose 2,963% to $16.7M. The stock fell 90% in FY2024 (Dec).
    DEF 14A
  7. Pay
    Filana Therapeutics President pay fell 41% to $3.7M. The stock fell 90% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Filana Therapeutics Division head pay rose 11% to $3.3M. The stock fell 90% in FY2024 (Dec).
    DEF 14A
  9. Pay
    Filana Therapeutics CFO pay rose 29% to $3.9M. The stock fell 90% in FY2024 (Dec).
    DEF 14A
  10. Board
    Claude Nicaise, M.D. joined the board of Filana Therapeutics. Claude Nicaise, M.D. now sits on 4 public boards.
    3
  11. Pay
    Filana Therapeutics President pay rose 462% to $6.3M. The stock fell 24% in FY2023 (Dec).
    DEF 14A
  12. Pay
    Filana Therapeutics President pay fell 36% to $1.1M. The stock fell 32% in FY2022 (Dec).
    DEF 14A
  13. Pay
    Filana Therapeutics Division head pay rose 642% to $3.0M. The stock fell 24% in FY2023 (Dec).
    DEF 14A
  14. Pay
    Filana Therapeutics Division head pay fell 16% to $400.0K. The stock fell 32% in FY2022 (Dec).
    DEF 14A
  15. Pay
    Filana Therapeutics CFO pay rose 602% to $3.0M. The stock fell 24% in FY2023 (Dec).
    DEF 14A
  16. Pay
    Filana Therapeutics CFO pay fell 45% to $426.6K. The stock fell 32% in FY2022 (Dec).
    DEF 14A
  17. Pay
    Filana Therapeutics Chief Operating and Legal Officer pay fell 65% to $1.3M. The stock fell 24% in FY2023 (Dec).
    DEF 14A
  18. Board
    Robert Anderson, Jr. joined the board of Filana Therapeutics. Robert Anderson, Jr. sits on no other public board.
    3
  19. Board
    Pierre Gravier joined the board of Filana Therapeutics. Pierre Gravier sits on no other public board.
    3

Filings6

See all
Proxy statementDEF 14AApr 28, 2026FY2025
Annual report10-KMar 12, 2026FY2025
Proxy statementDEF 14AApr 14, 2025FY2024
Annual report10-KMar 3, 2025FY2024
Proxy statementDEF 14AMar 26, 2024FY2023
Annual report10-KFeb 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data